(Q28247348)

6

0 references

Juhani Knuuti

Juhani Knuuti

8

0 references

Olli Raitakari

7

Olli T Raitakari

0 references

Pirjo Nuutila

5

Pirjo Nuutila

0 references

Tuula Janatuinen

1

Tuula Janatuinen

0 references

Reijo Laaksonen

3

Reijo Laaksonen

0 references

Risto Vesalainen

4

Risto Vesalainen

0 references

author name string

Juha Laakso

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

2

0 references

language of work or name

English

0 references

publication date

2003

0 references

published in

Vascular Medicine

0 references

volume

8

0 references

issue

3

0 references

page(s)

185-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM490OA